01/06/2026
In our previous article, we examined the expanding powers of the Federal Committee of Inquiry and the increasing compliance risks facing pharmacists at a Commonwealth level.
This follow‑up article focuses on a significant and emerging shift at the state level, where disciplinary proceedings may no longer remain confined to state regulators. In certain circumstances, state‑based findings can now trigger immediate federal consequences, placing a pharmacy’s PBS approval — and therefore the viability of the business, directly at risk.
The article explains how this regulatory crossover is unfolding, why the risk is no longer theoretical, and what pharmacy owners should be considering when responding to disciplinary action. What may once have been viewed as a contained state process can now escalate quickly, making early and informed legal advice critical.
Together with Part 1, this article highlights a changing regulatory landscape for pharmacy owners, where governance, compliance and proactive risk management are more important than ever.
Read the full article here:
https://www.bennettphilp.com.au/blog/new-risks-for-pharmacy-owners-facing-state-disciplinary-proceedings-now-the-pbs-approval-may-be-immediately-at-risk
For further information or advice, please contact Andrew Lambros